Hrt Financial LP Exelixis, Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Exelixis, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 120,089 shares of EXEL stock, worth $4.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

120,089

Previous 198,990 39.65%

Holding current value

$4.28 Million

Previous $4.47 Million 30.31%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$21.96 - $27.6 $1.73 Million - $2.18 Million	-78,901 Reduced 39.65%	120,089 $3.12 Million
Q2 2024 Aug 12, 2024	BUY	$20.34 - $23.73 $3.01 Million - $3.51 Million	147,955 Added 289.91%	198,990 $4.47 Million
Q1 2024 May 13, 2024	SELL	$20.17 - $23.93 $842,238 - $999,245	-41,757 Reduced 45.0%	51,035 $1.21 Million
Q4 2023 Feb 09, 2024	SELL	$19.25 - $24.13 $12.9 Million - $16.2 Million	-672,708 Reduced 87.88%	92,792 $2.23 Million
Q3 2023 Nov 13, 2023	BUY	$19.04 - $22.74 $14.6 Million - $17.4 Million	765,500 New	765,500 $16.7 Million
Q1 2023 May 12, 2023	SELL	$16.3 - $19.41 $1.26 Million - $1.5 Million	-77,377 Reduced 58.96%	53,855 $1.05 Million
Q4 2022 Feb 10, 2023	BUY	$14.96 - $17.39 $1.09 Million - $1.27 Million	72,797 Added 124.58%	131,232 $2.1 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $272,722 - $387,342	-17,393 Reduced 22.94%	58,435 $916,000
Q2 2022 Aug 12, 2022	SELL	$17.44 - $23.16 $3.29 Million - $4.37 Million	-188,723 Reduced 71.34%	75,828 $1.58 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $2.69 Million - $3.58 Million	157,793 Added 147.8%	264,551 $6 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $607,543 - $839,207	38,355 Added 56.07%	106,758 $1.95 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $1.11 Million - $1.45 Million	68,403 New	68,403 $1.45 Million
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $457,377 - $616,800	-24,871 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$20.67 - $26.94 $514,083 - $670,024	24,871 New	24,871 $608,000
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $1.11 Million - $1.42 Million	-62,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.93 - $24.75 $1.18 Million - $1.55 Million	62,500 New	62,500 $1.34 Million
Q2 2018 Aug 15, 2018	SELL	$18.56 - $22.45 $1.15 Million - $1.4 Million	-62,203 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$22.15 - $31.89 $1.38 Million - $1.98 Million	62,203 New	62,203 $1.38 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account